middle.news
Control Bionics Raises $3.25M to Accelerate Neurotech Commercialisation
3:01pm on Monday 1st of December, 2025 AEDT
•
Medical Devices
Read Story
Control Bionics Raises $3.25M to Accelerate Neurotech Commercialisation
3:01pm on Monday 1st of December, 2025 AEDT
Key Points
Raised $3.25 million via placement of 50 million shares at $0.065 each
Placement discounted 6.4% to recent VWAP and anchored by Reitham Equity GmbH
Funds to accelerate commercialisation of NeuroNode and NeuroStrip technologies
Focus on assistive communication, rehabilitation, and sports performance markets
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Control Bionics (ASX:CBL)
OPEN ARTICLE